Plasmapp
플라즈맵 · 405000
Health Care Medical Devices · KOSDAQ
Market cap US$15.6M (₩21.5B)
Overview
Plasmapp makes plasma-based sterilisation systems, devices that use ionised gas to kill pathogens on surgical instruments quickly and at low temperatures, along with surface-activation and dental-treatment devices built on the same core plasma technology.
Its products are used in hospitals and clinics of varying sizes, with its sterilisation line targeting mid-sized surgical centres and specialty clinics rather than only large general hospitals. Listed on KOSDAQ, Korea's tech-focused small-cap board, the company's sterilisation product line is its primary commercial focus, offered in multiple configurations under a single product family.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$9.4M
- FY2024US$7.3M
- FY2025US$6.1M
Operating profit
- FY2023−US$14.9M
- FY2024−US$12.8M
- FY2025−US$5.5M
Net income
- FY2023−US$13.6M
- FY2024−US$15.1M
- FY2025−US$4.8M
Key ratios (FY2025)
Why it matters
Plasmapp was founded out of a physics laboratory at KAIST, one of Korea's leading science and technology universities, giving it an academic research origin uncommon among listed medical-device companies.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?